|
Ye.V. Biryukova (1), M.B. Antsiferov (2)
How To Effectively Manage Two Major Defects In Type 2 Diabetes Mellitus?
|
№3 / 2012
|
|
O. M. Smirnova, I.V. Kononenko
Sulfonylureas In The Treatment Of Type 2 Diabetes Mellitus Today. Is There A Prospect?
|
№3 / 2012
|
|
M.B. Antsiferov
Application Of Vildagliptin In Combination With Insulin In Type 2 Diabetes Mellitus
|
№3 / 2012
|
|
I.V. Druk, G.I. Nechayeva, O.Yu. Korennova
Sitagliptin: Current Positions And Prospects For Therapy Of Type 2 Diabetes Mellitus
|
№3 / 2012
|
|
M.B. Antsiferov
Glucagon-like Peptide-1: From Physiology To Effective Management Of Type 2 Diabetes Mellitus
|
№3 / 2012
|
|
M.B. Antciferov
Galvus And Galvus Met In Treatment Of Elderly Patients With Type 2 Diabetes Mellitu
|
№16 / 2011
|
|
M.B. Antciferov
Dipeptidyl Peptidase-4 Inhibitors - New Potentials For Treatment Of Type 2 Diabetes Mellitus: Experience Of Use Of Galvus Met In Real-life Clinical Practice In Moscow
|
№16 / 2011
|
|
O.M. Smirnova, I.V. Kononenko
Diabeton Mb In The Treatment Of Type 2 Diabetes Mellitus And Prevention Of Its Late Complications
|
№16 / 2011
|
|
N.A. Petunina, A.V. Brashcenkova
Saxagliptin (onglyza ®) In Conception Of Effective Management Of Type 2 Diabetes Mellitus
|
№16 / 2011
|
|
T.I. Severina, Ye.N. Popkova, N.Yu. Trelskaya, V.V. Yemelyanov
Clinical And Metabolic Efficiency Of Drug Dibikor In Patients With Type 2 Diabetes Mellitus
|
№5 / 2011
|
|
Glinkina I.V., Romancova T.I.
Results Of Observational Program On Use Of Insulin Glargine (lantus®) In Combination With Oral Hypoglycemic Agents For The Treatment Of Type 2 Diabetes Mellitus In Routine Clinical Practice
|
№3 / 2011
|
|
Anciferov M.B.
Clinical Aspects For Use Of Dipeptidyl Peptidase-4 Inhibitors In Combination With Metformin: Benefits For Different Groups Of Patients
|
№3 / 2011
|
Русский
